Innoviva Inc (INVA.OQ)
INVA.OQ on NASDAQ Stock Exchange Global Select Market
14.10USD
4:00pm EDT
14.10USD
4:00pm EDT
Change (% chg)
$0.01 (+0.07%)
$0.01 (+0.07%)
Prev Close
$14.09
$14.09
Open
$14.10
$14.10
Day's High
$14.33
$14.33
Day's Low
$14.01
$14.01
Volume
334,857
334,857
Avg. Vol
305,945
305,945
52-wk High
$17.98
$17.98
52-wk Low
$11.47
$11.47
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 52.38 | 0.260 |
| FY 2017 | Dec '17 | 69.52 | 0.490 |
| Sep '17 | 48.64 | 0.198 | |
| Jun '17 | 58.56 | 0.292 | |
| Mar '17 | 40.49 | 0.140 | |
| FY 2016 | Dec '16 | 43.61 | 0.161 |
| Sep '16 | 33.31 | 0.123 | |
| Jun '16 | 32.47 | 0.117 | |
| Mar '16 | 24.18 | 0.039 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 3 | 72.14 | 77.70 | 68.50 | 60.41 |
| Quarter Ending Sep-18 | 3 | 70.84 | 73.20 | 69.20 | 61.71 |
| Year Ending Dec-18 | 4 | 269.68 | 284.00 | 232.90 | 246.22 |
| Year Ending Dec-19 | 4 | 307.57 | 368.07 | 226.12 | 256.77 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 3 | 0.52 | 0.55 | 0.50 | 0.37 |
| Quarter Ending Sep-18 | 3 | 0.51 | 0.54 | 0.46 | 0.38 |
| Year Ending Dec-18 | 4 | 1.79 | 2.02 | 1.42 | 1.42 |
| Year Ending Dec-19 | 4 | 2.18 | 2.91 | 1.37 | 1.65 |
| LT Growth Rate (%) | 1 | 19.34 | 19.34 | 19.34 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 11.36 | 28.66 | 32.90 | |
| P/E High - Last 5 Yrs. | 22.15 | 41.40 | 47.21 | |
| P/E Low - Last 5 Yrs. | 12.68 | 23.48 | 24.78 | |
| Beta | 2.05 | 0.80 | 0.79 | |
| Price to Sales (TTM) | 6.24 | 3.42 | 8.29 | |
| Price to Book (MRQ) | -- | 3.60 | 4.33 | |
| Price to Tangible Book (MRQ) | -- | 4.46 | 5.85 | |
| Price to Cash Flow (TTM) | 8.84 | 19.59 | 21.98 | |
| % Owned Institutions | 74.97 | 1.27 | 2.41 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.78 | 1.65 | |
| Dividend Yield - 5 Year Avg | -- | 0.78 | 0.80 | |
| Dividend 5 Year Growth Rate | -- | 2.67 | 4.07 | |
| Payout Ratio(TTM) | 0.00 | 16.62 | 17.46 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 29.36 | 3.79 | 4.91 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 52.85 | 10.43 | 12.76 | |
| Sales - 5 Yr. Growth Rate | 9.86 | 7.39 | 8.10 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 86.08 | 39.00 | 35.43 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 129.08 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 7.03 | 8.55 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 8.06 | 8.61 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.55 | 2.53 |
| Current Ratio (MRQ) | 27.85 | 3.62 | 3.60 |
| LT Debt to Equity (MRQ) | -- | 10.57 | 12.91 |
| Total Debt to Equity (MRQ) | -- | 13.08 | 15.97 |
| Interest Coverage (TTM) | 2.35 | 39.94 | 34.81 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 55.35 | 54.97 | |
| Gross Margin - 5 Yr. Avg. | -- | 52.67 | 52.78 | |
| EBITD Margin (TTM) | 91.19 | -- | -- | |
| EBITD - 5 Yr. Avg | 76.36 | 18.49 | 15.93 | |
| Operating Margin (TTM) | 85.09 | 14.61 | 0.12 | |
| Operating Margin - 5 Yr. Avg. | 62.59 | 14.23 | 11.20 | |
| Pre-Tax Margin (TTM) | 64.49 | 14.89 | 2.20 | |
| Pre-Tax Margin - 5 Yr. Avg. | 16.97 | 14.51 | 11.41 | |
| Net Profit Margin (TTM) | 64.49 | 11.29 | -1.22 | |
| Net Profit Margin - 5 Yr. Avg. | 16.97 | 10.80 | 7.70 | |
| Effective Tax Rate (TTM) | 0.00 | 22.50 | 31.30 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 23.91 | 24.62 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 19,092,080 | 841,727,147 | 731,572,994 | |
| Net Income/Employee (TTM) | 12,313,080 | 97,990,015 | 85,104,893 | |
| Receivable Turnover (TTM) | 4.60 | 5.60 | 5.75 | |
| Inventory Turnover (TTM) | -- | 2.52 | 3.58 | |
| Asset Turnover (TTM) | 0.69 | 0.88 | 0.86 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 44.20 | 10.56 | 10.07 | |
| Return on Assets - 5 Yr. Avg. | 3.01 | 11.70 | 11.12 | |
| Return on Investment (TTM) | 45.94 | 13.20 | 12.74 | |
| Return on Investment - 5 Yr. Avg. | 3.23 | 15.12 | 14.40 | |
| Return on Equity (TTM) | -- | 14.95 | 14.64 | |
| Return on Equity - 5 Yr. Avg. | -- | 16.37 | 15.76 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 62.63 | 195.33 | 9.86 |
| EPS (TTM) % | 131.64 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Innoviva Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -10.77 | -13.71 | 24 | 14 |
| 13 Week | -14.29 | -14.55 | 33 | 12 |
| 26 Week | 5.07 | 0.23 | 60 | 13 |
| 52 Week | 16.64 | 2.49 | 67 | 12 |
| YTD | -0.70 | -2.56 | 60 | 11 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Innoviva Names Geoffrey Hulme As Interim Principal Executive Officer
- BRIEF-Innoviva Reports Q1 Adjusted Earnings Per Share $0.35
- BRIEF-Sarissa Capital Reconstitutes Innoviva Board
- BRIEF-Innoviva Enteres Into Agreement With Sarissa Capital Management
- Drug company Innoviva settles with activist hedge fund Sarissa: sources
Institutional Holders
| % Shares Owned: | 74.96% |
| # of Holders: | 304 |
| Total Shares Held: | 76,064,306 |
| 3 Mo. Net Change: | -2,154,494 |
| # New Positions: | 51 |
| # Closed Positions: | 21 |
| # Increased Positions: | 136 |
| # Reduced Positions: | 121 |
| # Net Buyers: | 15 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.